OR WAIT null SECS
The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.
April 25, 2024
Video
Matthew Nudy, MD, discusses a trio of meta-analyses examining the effects of intensive blood pressure control on various targets.
April 03, 2024
Article
April 02, 2024
A recap of the biggest FDA news and decisions in cardiovascular medicine from the first 3 months of 2024, with commentary on recent announcements by Deepak Bhatt, MD, MPH, MBA.
March 25, 2024
Michael Weber, MD, lead of the PRECISION trial, discusses the significance of the aprocitentan (Tryvio) approval and key points for providers who may have patients with uncontrolled hypertension.
March 22, 2024
The approval marks the first and only once-daily single-tablet combination therapy for patients with pulmonary arterial hypertension.
March 20, 2024
Idorsia Ltd. announced the FDA's approval of aprocitentan (Tryvio) for treatment-resistant hypertension on March 20, 2024.
March 15, 2024
Patients whose primary care practitioners were randomized to a clinical decision support system intervention achieved a statistically significant reduction in SBP versus usual care but had similar rates of BP control.
March 05, 2024
In new topline results from the KARDIA-2 trial, zilebesiran added to standard-of-care antihypertensive treatments showed significant reductions in systolic blood pressure.
February 16, 2024
Older adults who use a salt substitute had a 40% lower incidence of experiencing hypertension than people who use regular salt.
February 09, 2024
A recent survey indicates many US adults are unaware of their vital health metrics, highlighting the need for increased education on heart disease prevention.